Skip to content
★ Sign in to follow
EW

Eric Wachter PhD

Executive
Provectus Biopharmaceuticals, Inc.
Total declarations
42
Company
1
▲ Purchases (1 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 31 Mar 2016 for PROVECTUS BIOPHARMACEUTICALS, INC., €178k.

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Eric Wachter PhD: trading record in brief

Eric Wachter PhD is a declared insider of Provectus Biopharmaceuticals, Inc., with filings sourced from SEC (Form 4). The record holds 42 filings, for trades running from 4 January 2006 to 29 March 2016.

The open-market record is one-sided, with 1 purchase and not one sale. The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 39 option exercises.

On 31 March 2016 came the latest disclosure, a transaction for €94k in Provectus Biopharmaceuticals, Inc. The last insider purchase was made public on 20 November 2012, 5,101 days ago. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Eric Wachter PhD

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations42 total

25 of 42 declarations